← back to search

Fanfan Zhou

The University of Sydney · AU
Area of research
Oncology · Ophthalmology
Research interest
Research interests include Drug Transport and Resistance Mechanisms, Retinal Development and Disorders, Amino Acid Enzymes and Metabolism, and Retinal Diseases and Treatments.
h-index
36
citations
3,703
works
167
NIH funding
primary concept
email

Recent publications

Recent advances in 3D cell culture models in cancer drug development
Journal of Pharmaceutical Investigation 2025cited by 7position: lastdoi
Cortical Actin Depolymerisation in 3D Cell Culture Enhances Extracellular Vesicle Secretion and Therapeutic Effects
Journal of Extracellular Vesicles 2025cited by 5position: middledoi
Erdafitinib promotes ferroptosis in human uveal melanoma by inducing ferritinophagy and lysosome biogenesis via modulating the FGFR1/mTORC1/TFEB signaling axis
Free Radical Biology and Medicine 2024cited by 17position: lastdoi
Research hotspots and trends of mesenchymal stem cell-derived extracellular vesicles for drug delivery: a bibliometric and visualization analysis from 2013 to 2023
Frontiers in Cell and Developmental Biology 2024cited by 5position: middledoi
Recent advances and prospects for lipid-based nanoparticles as drug carriers in the treatment of human retinal diseases
Advanced Drug Delivery Reviews 2023cited by 40position: middledoi
Structure–Interaction Relationship of Polymyxins with Lung Surfactant
Journal of Medicinal Chemistry 2023cited by 9position: middledoi
Procyanidin B2 and rutin in Ginkgo biloba extracts protect human retinal pigment epithelial (RPE) cells from oxidative stress by modulating Nrf2 and Erk1/2 signalling
Experimental Eye Research 2021cited by 43position: lastdoi
The involvement of human organic anion transporting polypeptides (OATPs) in drug-herb/food interactions
Chinese Medicine 2020cited by 36position: lastdoi
Optimization of inhalable liposomal powder formulations and evaluation of their in vitro drug delivery behavior in Calu-3 human lung epithelial cells
International Journal of Pharmaceutics 2020cited by 30position: middledoi
Impaired Transport Activity of Human Organic Anion Transporters (OATs) and Organic Anion Transporting Polypeptides (OATPs) by Wnt Inhibitors
Journal of Pharmaceutical Sciences 2020cited by 10position: lastdoi
Human macular Müller cells rely more on serine biosynthesis to combat oxidative stress than those from the periphery
eLife 2019cited by 50position: middledoi
Simvastatin protects photoreceptors from oxidative stress induced by all‐<scp><i>trans</i></scp>‐retinal, through the up‐regulation of interphotoreceptor retinoid binding protein
British Journal of Pharmacology 2019cited by 11position: middledoi
Disruption of De Novo Serine Synthesis in Müller Cells Induced Mitochondrial Dysfunction and Aggravated Oxidative Damage
Molecular Neurobiology 2018cited by 64position: middledoi
Paeoniflorin attenuates atRAL-induced oxidative stress, mitochondrial dysfunction and endoplasmic reticulum stress in retinal pigment epithelial cells via triggering Ca2+/CaMKII-dependent activation of AMPK
Archives of Pharmacal Research 2018cited by 54position: middledoi
A derivative of betulinic acid protects human Retinal Pigment Epithelial (RPE) cells from cobalt chloride-induced acute hypoxic stress
Experimental Eye Research 2018cited by 26position: lastdoi
The inhibitory effects of eighteen front-line antibiotics on the substrate uptake mediated by human Organic anion/cation transporters, Organic anion transporting polypeptides and Oligopeptide transporters in in vitro models
European Journal of Pharmaceutical Sciences 2018cited by 12position: lastdoi
Puerarin inhibits amyloid β-induced NLRP3 inflammasome activation in retinal pigment epithelial cells via suppressing ROS-dependent oxidative and endoplasmic reticulum stresses
Experimental Cell Research 2017cited by 75position: middledoi
Trafficking and other regulatory mechanisms for organic anion transporting polypeptides and organic anion transporters that modulate cellular drug and xenobiotic influx and that are dysregulated in disease
British Journal of Pharmacology 2017cited by 52position: lastdoi
Amyloid β induces NLRP3 inflammasome activation in retinal pigment epithelial cells via NADPH oxidase‐ and mitochondria‐dependent ROS production
Journal of Biochemical and Molecular Toxicology 2016cited by 74position: middledoi
Recent advance in the pharmacogenomics of human Solute Carrier Transporters (SLCs) in drug disposition
Advanced Drug Delivery Reviews 2016cited by 71position: firstdoi
Chloroquine and Hydroxychloroquine Are Novel Inhibitors of Human Organic Anion Transporting Polypeptide 1A2
Journal of Pharmaceutical Sciences 2015cited by 82position: lastdoi
Human oligopeptide transporter 2 (PEPT2) mediates cellular uptake of polymyxins
Journal of Antimicrobial Chemotherapy 2015cited by 80position: lastdoi
Puerarin Protects Human Neuroblastoma SH‐SY5Y Cells against Glutamate‐Induced Oxidative Stress and Mitochondrial Dysfunction
Journal of Biochemical and Molecular Toxicology 2015cited by 47position: lastdoi
Investigation of Gallic Acid Induced Anticancer Effect in Human Breast Carcinoma MCF‐7 Cells
Journal of Biochemical and Molecular Toxicology 2014cited by 95position: lastdoi
Ziyuglycoside II induces cell cycle arrest and apoptosis through activation of ROS/JNK pathway in human breast cancer cells
Toxicology Letters 2014cited by 69position: lastdoi
Selective Inhibition of Human Solute Carrier Transporters by Multikinase Inhibitors
Drug Metabolism and Disposition 2014cited by 65position: middledoi
Protective Effect of Paeoniflorin on Aβ25–35-Induced SH-SY5Y Cell Injury by Preventing Mitochondrial Dysfunction
Cellular and Molecular Neurobiology 2013cited by 95position: lastdoi
Functional Analysis of Novel Polymorphisms in the Human SLCO1A2 Gene that Encodes the Transporter OATP1A2
The AAPS Journal 2013cited by 51position: firstdoi
The Expression of ABC Efflux Pump, Rv1217c–Rv1218c, and Its Association with Multidrug Resistance of Mycobacterium tuberculosis in China
Current Microbiology 2012cited by 78position: lastdoi
Role of human CYP3A4 in the biotransformation of sorafenib to its major oxidized metabolites
Biochemical Pharmacology 2012cited by 64position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Ling Zhu · The George Institute for Global Health21 papers (2013–2025)Xue Zhu · Shanghai University11 papers (2012–2025)Ke Wang · Nanjing Brain Hospital11 papers (2012–2025)Michael T. Murray · The University of Sydney10 papers (2012–2025)Kai Zhang · South China Agricultural University6 papers (2013–2017)Ting Zhang · National Institutes of Health5 papers (2018–2023)Mark C. Gillies · The University of Sydney5 papers (2015–2023)Xiaofeng Bao · Nantong University4 papers (2018–2021)Zhengqi Cheng · Kunming University of Science and Technology4 papers (2018–2021)Weiyong Shen · The University of Sydney4 papers (2015–2019)Jian Li · Biomedicine Discovery Institute4 papers (2015–2023)Ting Chan · The University of Melbourne4 papers (2014–2018)Qi Zhou · Purdue University West Lafayette4 papers (2015–2023) · 3 papers (2020–2021)Michele C. Madigan · UNSW Sydney3 papers (2015–2019)Xiaoxi Lu · Nanfang Hospital3 papers (2015–2018)Shaoxue Zeng · The University of Sydney3 papers (2019–2023)Wenying Shu · Guangzhou Medical University3 papers (2020–2021)Hak‐Kim Chan · The University of Sydney3 papers (2015–2020)Jianhai Du · Medical College of Wisconsin2 papers (2018–2019)